A Big Drug From A Small Biotech
13th Nov 2006, 19:22 GMT
The cholesterol-lowering treatment from Isis Pharmaceuticals may be more potent than anything now on the market.
A Big Drug From A Small Biotech related news:
- Amazon Biotech, Inc: Amazon Biotech Inc. Announces Union Bless Herbal Products' Application for Amendment to Approved Import Drug License to Include Amazon Biotech as Approved Supplier — Market Wire - Pharmaceuticals and Biotech
- Amazon Biotech Inc. Announces Union Bless Herbal Products' Application for Amendment to Approved Import Drug License to Include Amazon Biotech as Approved Supplier — ArriveNet : Health
- Controversy surrounds failed test drug results — Financial news of the day - CNNMoney.com
- Scientists Find New Painkiller From Saliva — Slashdot: Science
- Drug stocks pare gains; Solexa, Isis shares soar — MarketWatch.com - Top Stories – Sponsored by: CyberTrader
- BioTech Medics, Inc.: BioTech Medics Announces Pinksheets Quotation — Market Wire - Medical and Healthcare
- Nautilus Biotech und Creabilis Therapeutics erreichen technischen Meilenstein bei Zusammenarbeit zur Verbesserung der HMGB1 Box A für die Behandlung von mit RAGE und HMGB1 zusammenhängenden Pathologien. — Presseportal
- Tests Ahead for Biotech Stocks — RealMoney by TheStreet.com
- Nonprofits starting to invest in drug companies — bizjournals.com Health Care:Pharmaceuticals headlines
- Analyst Sees Possible Biotech — Government/ Industry Regulation News from StratCenter.com
Latest news from Forbes.com Business News:
- Auditor Infantilism: Where Are The Limits?
- Eddie Bauer In Private Equity Deal
- Old People Like Web Video!
- 50,000 Unnecessary Heart Procedures
- Mets Break The Bank
- US Airways Offers $8B For Delta
- A Trip-Up Before Key Trip
- Noodle Maker Myojo Slipping Away From Bidder
- Fresh, Healthy Food Boosts Sainsbury's
- Six Ways Congress Could Hurt Big Pharma